chr20-62957513-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6BP7BA1
The ENST00000370351.9(SLC17A9):c.330C>T(p.Leu110=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0612 in 1,610,046 control chromosomes in the GnomAD database, including 3,380 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (no stars).
Frequency
Genomes: 𝑓 0.050 ( 268 hom., cov: 33)
Exomes 𝑓: 0.062 ( 3112 hom. )
Consequence
SLC17A9
ENST00000370351.9 synonymous
ENST00000370351.9 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.495
Genes affected
SLC17A9 (HGNC:16192): (solute carrier family 17 member 9) This gene encodes a member of a family of transmembrane proteins that are involved in the transport of small molecules. The encoded protein participates in the vesicular uptake, storage, and secretion of adenoside triphosphate (ATP) and other nucleotides. A mutation in this gene was found in individuals with autosomal dominant disseminated superficial actinic porokeratosis-8. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.72).
BP6
Variant 20-62957513-C-T is Benign according to our data. Variant chr20-62957513-C-T is described in ClinVar as [Benign]. Clinvar id is 3056817.Status of the report is no_assertion_criteria_provided, 0 stars.
BP7
Synonymous conserved (PhyloP=-0.495 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.069 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC17A9 | NM_022082.4 | c.330C>T | p.Leu110= | synonymous_variant | 3/13 | ENST00000370351.9 | NP_071365.4 | |
SLC17A9 | NM_001302643.2 | c.312C>T | p.Leu104= | synonymous_variant | 4/14 | NP_001289572.2 | ||
SLC17A9 | XM_011528978.3 | c.-31C>T | 5_prime_UTR_variant | 2/12 | XP_011527280.1 | |||
SLC17A9 | XR_936601.4 | n.452C>T | non_coding_transcript_exon_variant | 3/10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC17A9 | ENST00000370351.9 | c.330C>T | p.Leu110= | synonymous_variant | 3/13 | 1 | NM_022082.4 | ENSP00000359376 | P1 | |
SLC17A9 | ENST00000370349.7 | c.312C>T | p.Leu104= | synonymous_variant | 4/14 | 1 | ENSP00000359374 | |||
SLC17A9 | ENST00000411611.1 | c.390C>T | p.Leu130= | synonymous_variant | 3/3 | 2 | ENSP00000388215 | |||
SLC17A9 | ENST00000488738.5 | n.450C>T | non_coding_transcript_exon_variant | 3/11 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0500 AC: 7605AN: 152148Hom.: 268 Cov.: 33
GnomAD3 genomes
AF:
AC:
7605
AN:
152148
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0519 AC: 12707AN: 244648Hom.: 480 AF XY: 0.0529 AC XY: 7041AN XY: 133090
GnomAD3 exomes
AF:
AC:
12707
AN:
244648
Hom.:
AF XY:
AC XY:
7041
AN XY:
133090
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0624 AC: 90936AN: 1457780Hom.: 3112 Cov.: 34 AF XY: 0.0612 AC XY: 44415AN XY: 725264
GnomAD4 exome
AF:
AC:
90936
AN:
1457780
Hom.:
Cov.:
34
AF XY:
AC XY:
44415
AN XY:
725264
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0499 AC: 7605AN: 152266Hom.: 268 Cov.: 33 AF XY: 0.0508 AC XY: 3782AN XY: 74440
GnomAD4 genome
AF:
AC:
7605
AN:
152266
Hom.:
Cov.:
33
AF XY:
AC XY:
3782
AN XY:
74440
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
57
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
SLC17A9-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Apr 15, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at